SCHEMBL30458214

SCHEMBL30458214

COc1cc(OC)cc(C(C(=O)OCc2ccccc2)C(=O)OCc2ccccc2)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
ATM Q13315 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
MAOB P27338 1/20 0.47
TACR1 P25103 2/20 0.47
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
ACHE P22303 2/20 0.46
GAA P10253 1/20 0.46
ELANE P08246 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
MAPK1 P28482 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A3 Q01959 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18978364 0.83 MTNR1A (0.51) ATML3MBTL1MAOBKMT2ANPC1
SCHEMBL18978326 0.81 ATM (0.56) ALDH1A1ATML3MBTL1CA1CA2
SCHEMBL11526737 0.80 ALDH1A1 (0.57) ALDH1A1L3MBTL1ELANEKMT2AMAPK1
SCHEMBL1275072 0.80 L3MBTL1 (0.49) ALDH1A1ATML3MBTL1TACR1GAA
SCHEMBL18978361 0.79 MTNR1A (0.47) ALDH1A1ATML3MBTL1MAOBGAA
SCHEMBL27499976 0.79 CA1 (0.45) ALDH1A1ATML3MBTL1TACR1CA1
SCHEMBL23718140 0.78 CASR (0.53) ATML3MBTL1MAOBKMT2A
SCHEMBL28209670 0.78 KMT2A (0.64) ALDH1A1L3MBTL1MAOBGAANPSR1
SCHEMBL7187090 0.78 CA1 (0.44) ALDH1A1ATML3MBTL1TACR1CA1
SCHEMBL21336450 0.77 CASR (0.52) ATML3MBTL1MAOBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4444708-B1 MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF PFIZER (US) 2025-07-30 EP disclosed
US-20250129048-A1 MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF PFIZER INC. (US) 2025-04-24 US disclosed
EP-4444708-A1 MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF Pfizer Inc. (US) 2024-10-16 EP disclosed
WO-2023105387-A1 MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF PFIZER INC. (US) 2023-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129048-A1 MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF MC4R, MC3R, MC2R ALDH1A1 3955/4885ATM 3249/4885L3MBTL1 2032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.